Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06356181
Other study ID # Pro00135143
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 18, 2024
Est. completion date September 1, 2024

Study information

Verified date April 2024
Source University of South Carolina
Contact Shawn J Arent, PhD
Phone 8035768394
Email sarent@mailbox.sc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This project aims to assess the effectiveness of using a Respiratory Muscle Training (RMT) device during high-intensity functional training (HIFT) to improve fitness and ventilatory parameters. Primary outcome measures include aerobic, anaerobic, and HIFT measures. Secondary measures include sleep, affect, and mood state questionnaires. Participants will be randomized into one of two groups: with the RMT device and without the RMT device.


Description:

This study assesses the impact of a ventilatory training device, similar to a sports mouth guard worn during exercise, on various performance outcomes. The main questions it aims to answer are: - Does the device improve fitness parameters: high-intensity functional training, anaerobic capacity, anaerobic peak and mean power output, maximal oxygen uptake, ventilatory threshold, and blood lactate responses to training? - Does the device improve spirometry measures? Researchers will compare 6 weeks of training with the ventilatory training device to those without the training device. Participants will: - Take part in a total of 8 weeks of study-related activity. - Complete six total one- to two-hour pre- and post-testing sessions, which include a maximal oxygen uptake test, high-intensity functional training, body composition, spirometry, anaerobic power and capacity testing. - Complete six weeks of 45-minute high-intensity functional training, three days per week.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date September 1, 2024
Est. primary completion date September 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - Males and females between the ages of 18 and 35 (inclusive) who participate in at least 150 minutes per week of physical activity. - Have not participated in HIFT training in the last 6 months. - Provided written and dated informed consent to participate in the study. - In good health as determined by medical history and is cleared for exercise. - Participant will be asked about dietary supplementation use within the past 6 months. - If participant began taking a supplement within the past month, subject will be asked to discontinue supplement use followed by a 2-week washout prior to participation. - In all other cases, we will request that participant maintain supplement use. Exclusion Criteria: - Any musculoskeletal injuries that would prevent exercising. - Any metabolic disorder including known electrolyte abnormalities, diabetes, uncontrolled thyroid disease, adrenal disease or hypogonadism. - Any inborn error of metabolism. - History of hepatorenal, musculoskeletal, autoimmune, or neurologic disease. - Participants with a personal history of heart disease, high blood pressure (systolic >140 mm Hg & diastolic >90 mm Hg), - Participants who are pregnant, planning to become pregnant, or lactating.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Respiratory Maximus Training Device
Those in the intervention group will wear the respiratory training device for 3 days per week of high-intensity functional training over 6-weeks.
No Respiratory Training Device
Those in the control group will train for 3 days per week of high-intensity functional training over 6-weeks.

Locations

Country Name City State
United States University of South Carolina Sport Science Lab Columbia South Carolina

Sponsors (2)

Lead Sponsor Collaborator
University of South Carolina MAXIMUS

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in spirometry Spirometry measures of forced vital capacity (FVC) (L), forced expiratory volume at one second (FEV1) (L), and the ratio of FEV1/FVC % Baseline and Week 8
Primary Changes in aerobic capacity Assessed via a cycle-ergometer based maximal graded exercise test with indirect calorimetry. Baseline and Week 8
Primary Changes in peak power Assessed via a cycle-ergometer based maximal graded exercise test Baseline and Week 8
Primary Changes in ventilatory threshold Assessed via a cycle-ergometer based maximal graded exercise test with indirect calorimetry. Baseline and Week 8
Primary Changes in countermovement jump Assessed via force plates Baseline and Week 8
Primary Changes in anaerobic capacity Assessed via 30-second Wingate test. Baseline and Week 8
Primary Changes in high-intensity functional training test Assessed via a high-intensity functional training circuit composed of rows, pushups, and squats Baseline and Week 8
Primary Changes in heart rate at ventilatory threshold Assessed via a cycle-ergometer based maximal graded exercise test with indirect calorimetry. Baseline and Week 8
Secondary Changes in body composition Body fat percentage, fat-free mass, and fat mass via air-displacement plethysmography. Baseline and Week 8
Secondary Changes in sleep quality Assessed by Pittsburgh Sleep Quality Index. The minimum score is 0 and the maximum score is 40. Higher scores mean a worse outcome. Baseline and Weeks 3, 5, and 7
Secondary Changes in total mood disturbances Assessed by the Profile of Mood States (POMS). The total mood is calculated by adding the negative subscales (tension, depression, fatigue, confusion, and anger) and subtracting the positive subscales (vigor, esteem-related affect). Minimum score of -36 and max score of 200. Lower scores for total mood disturbance are considered better. Baseline and Weeks 3, 5, and 7
Secondary Changes in positive mood and emotion Assessed by the Positive and Negative Affect Schedule. Min values of 0 and max of 50, higher scores indicate more positive moods and emotions. Baseline and Weeks 3, 5, and 7
Secondary Change in blood lactate responses Biochemical responses to exercise. Blood lactate sampled pre and post exercise during the last training day of the week. Weeks 3, 5, and 7
Secondary Changes in negative mood and emotion Assessed by the Positive and Negative Affect Schedule. Min values of 0 and max of 50, higher scores indicate more negative moods and emotions with lower scores indicating less negative moods and emotions. Baseline and Weeks 3, 5, and 7.
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1